Home › Idiopathic Thrombocytopenic Purpura › Minnesota › Rochester
Idiopathic Thrombocytopenic Purpura clinical trials in Rochester, MN
4 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
RecruitingPhase 2
- Mayo Clinic Rochester, Rochester
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
RecruitingPhase 1/2
- Mayo Clinic, Rochester
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
RecruitingPhase 1/2
- Mayo Clinic in Rochester, Rochester
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
RecruitingPhase 3
- Mayo Clinic_Investigational Site Number: 8400009, Rochester
Idiopathic Thrombocytopenic Purpura trials in other cities
- Los Angeles, CA7 studies
- Washington, DC6 studies
- Greenville, NC6 studies
- Boston, MA6 studies
- The Bronx, NY5 studies
- Durham, NC4 studies
- Seattle, WA4 studies
- Portland, OR4 studies
- Houston, TX4 studies
- New Haven, CT3 studies
- Cedar Rapids, IA3 studies
- New Orleans, LA3 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Metastatic Cancer31 studies
- Cancer (all types)30 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Multiple Myeloma24 studies
- Heart Failure22 studies
- Prostate Cancer22 studies
- Pancreatic Cancer22 studies
- Endometrial Cancer20 studies
- Lung Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.